40+ Lab Automation Statistics (2026): Market Size, ROI, and Adoption

Most research firms put the laboratory automation market between USD 6.6 billion and USD 10 billion in 2026, though narrower-scope estimates run lower and the most bullish forecasts reach USD 24 billion within a decade.

This article rounds up over 40 lab automation statistics, including market size, trends, adoption numbers, and barriers to automation. 

And every statistic below traces to a market report, a peer-reviewed study, or a named industry survey. Where independent firms disagree, I’ll give you a range instead of an exact figure.

Let’s start with our top picks…

But first, please subscribe to the BestLabTech newsletter. Every week we send a curated list of the most useful tools, resources, and reads from across the lab tech world. Enter your email below to subscribe.

You may also like:

• 5 Best Lab Workflow Software Tools
  
• Why LIMS Implementations Still Fail Today
  
• What is a Unified Lab Platform?

Top Lab Automation Statistics

Short on time? These are the 10 strongest, most quotable numbers in the roundup.

• Most firms value the global lab automation market at USD 6.6B to 10B in 2026
  
• Forecast to USD 8.6B to 24B by the mid-2030s
  
• North America held 38% of the lab automation market in 2025
  
• Total laboratory automation cut discrete manual processing steps by 86%
   
• Automating blood-culture diagnostics cut overall turnaround time by 36.7%
  
• Anatomic pathology labs reported a 28.5% staff vacancy rate
  
• 77% of life-science labs expect to use AI within two years
  
• AI is the number one investment area at 63%
  
• Nearly 40% of labs run more than 100,000 clinical pathology tests a year
  
• 45% of QC executives name poor integration as the biggest barrier to automation

Sources: MarketsandMarkets, SNS Insider, Mordor Intelligence, PMC, Microbiology Spectrum, ASCP 2024 Vacancy Survey via AABB, Pistoia Alliance, ASCP 2024 Vacancy Survey via Dark Daily, Deloitte

How Big Is the Laboratory Automation Market?

Most estimates cluster between USD 6.5 billion and USD 10 billion for 2025/26, with forecasts reaching USD 8.6 billion to USD 24 billion by the early-to-mid 2030s and CAGRs from about 5.9% to 10.4%. 

A few firms using a narrower definition land closer to USD 2.5 billion.

The reason for the differences is because firms scope “lab automation” differently and use different base years.

(The table below lists these numbers, firm by firm, just in case you find the text in the chart too small. You can also click the image to make the chart bigger.)

The one thing every firm agrees on:

The market is compounding at mid-to-high single digits or better, and not one of them forecasts it shrinking.

Sources: MarketsandMarkets, Precedence Research, IMARC Group, Grand View Research, Fortune Business Insights, SNS Insider, Roots Analysis, Mordor Intelligence, FactMR, Future Market Insights 

Which Regions Lead Lab Automation Adoption?

North America leads, but Asia Pacific is closing fastest.

• North America contributed 38.11% of total lab automation revenue in 2025
  
• The US market alone was USD 2.23 billion in 2025
  
• Forecast to reach USD 3.97 billion by 2034, a 7% CAGR
  
• Asia Pacific is the fastest-growing region, at a 6.99% CAGR
  
• By country, the US is forecast to grow fastest at a 10.3% CAGR through 2036
  
• The EU is forecast to grow at 9.8%

Sources: Mordor Intelligence, Precedence Research. Future Market Insights

What Are Labs Actually Automating?

Automated liquid handlers held 37.83% of the equipment segment in 2025. 

LIMS software held 45.67% of the software segment. 

Analytical automation captured 50.21% of revenue by scope. 

Clinical diagnostics was the largest application at 43.92%. 

And hospitals and reference labs were the largest end users at 42.68%.

All of this comes from Mordor Intelligence’s 2025 segmentation of the total lab automation market.

I think the pattern for anyone covering the space is that the money sits in liquid handling on the hardware side, LIMS on the software side, and clinical diagnostics as the application pulling it all together.

Lab Robotics Is a USD 2.7 Billion Market on Its Own

The laboratory robotics market was worth USD 2.74 billion in 2025 and is forecast to reach roughly USD 5.41 billion by 2035, a 7.04% CAGR.

North America holds 40.52% of the market in 2025. 

A more conservative estimate puts it at USD 2.5 billion in 2025 growing at a 5.76% CAGR. 

The high-throughput screening market was worth USD 26.43 billion in 2025 and is forecast to reach USD 45.90 billion by 2031, a 10.7% CAGR.

Finally, the liquid handling systems market was worth USD 5.10 billion in 2025.

And it’s forecast to reach USD 7.48 billion by 2030, an 8.0% CAGR.

Basically, this means that when you zoom out from the core automation platforms, you can see the adjacent hardware and screening markets are large and growing in their own right.

Sources: Precedence Research, Mordor Intelligence, MarketsandMarkets

Total Lab Automation Cuts Manual Steps by 86%

Total lab automation cut discrete manual processing steps by 86% and reduced the testing footprint by 45%.

Other stats to know:

• Test productivity per capita rose by up to 42% after TLA
  
• Tests performed per worker increased 1.4 to 3.7-fold in a hospital case study
  
• 95% of automated tests were reported in under 120 minutes
  
• The top five vendors held roughly 93% of global lab automation revenue in the most recent breakdown 

Sources: PMC

Turnaround time is where automation shows up most clearly in recent studies.

For example, automating blood-culture diagnostics cut overall turnaround time by 36.7% (from 95.99 to 60.81 hours) and reduced total hospital cost per case by 39%, with no added staffing.

Also, direct automated identification and susceptibility testing from urine samples cut turnaround time by 35 to 43 hours versus conventional methods.

Sources: Microbiology Spectrum, Cureus

And on cost and error, the evidence is consistent across study designs:

For instance, a published economic evaluation found total lab automation improved turnaround-time predictability by 70%, dropped staff tube-touch moments by 77.6%, and paid back its capital cost in about 4.75 years, with projected six-year savings of USD 1.88 million. 

This is one of the most detailed peer-reviewed lab automation ROI datasets available, and a 2026 review reports a comparable 37% cut in manual steps and a four-to-five-year payback from a separate study. 

Other examples:

• 50% to 70% of all detectable laboratory errors still arise in the pre-analytical phase, the manual sample-handling stage automation targets first.
  
• 53% of biopharma executives saw increased lab throughput and 45% saw reduced human error from lab modernization. 

Sources: Annals of Laboratory Medicine, Diagnostics, Deloitte

Anatomic Pathology Labs Report a 28.5% Vacancy Rate

Anatomic pathology reported a 28.5% staff vacancy rate, the highest of any department, while cytogenetics was lowest at 7.7%. The survey drew 1,027 responses covering more than 18,626 US lab employees.

• 10 of the 17 lab departments surveyed reported rising retirement rates compared with the prior cycle
  
• Nearly 40% of respondents run more than 100,000 clinical pathology tests a year, the volume pressure automation exists to absorb
  
• The average clinical lab vacancy rate was 7.2%, and US training programs graduate less than half the lab professionals the field needs each year

Automation using pathology lab reporting software isn’t really a technology-push story. It’s demand and staffing pulling it in, and the 2024 ASCP vacancy survey, published across late 2025 and early 2026, shows why. 

That gap between test demand and available hands is what sits under the market-size charts. 

For most labs, automation is covering shifts they can’t staff rather than replacing people they already have.

Sources: ASCP 2024 Vacancy Survey via AABB, ASCP 2024 Vacancy Survey via Dark Daily, ASCLS / ASCP

How Fast Are Labs Adopting Automation and AI?

77% of life-science labs expect to use AI within two years. And AI is the number one investment area at 63%, stable for the third year running.

Electronic lab notebook software adoption rose to 81% in 2025, up from 66% a year earlier, and cloud platform use reached 80%, up from 70% in 2023.

17.4% of surveyed labs had incorporated AI tools, ranging from 33.3% in lab information systems and quality roles down to 7.2% in histology. 

So intent is running well ahead of deployment, and the Pistoia Alliance’s 2025 survey gives clean year-over-year deltas.

Sources: Pistoia Alliance, ASCP 2024 Vacancy Survey via CriticalValues

What’s Stopping Labs From Automating?

45% of QC executives name poor integration between systems as the top barrier to modernization, ahead of competing priorities (38%), leadership support (38%), and ROI (32%). 

Also:

• 34% of labs cite a lack of people or skills as a barrier to adopting AI and automation, up from 23% a year earlier, while only 9% now see regulation as a barrier
  
• Data silos remain the top data challenge at 57% for life-science labs
  
• 65.2% of lab staff are somewhat to moderately skeptical of AI, and 37.4% cite distrust in AI as a barrier to using it, a reminder that adoption is as much cultural as technical 

Data like this shows why not every lab is automated, despite the strong case for it. It’s because the blocker is rarely the robots. It’s integration, skills, and staff trust. Proper lab integration software is also a must for reliable automation. 

Sources: Deloitte, Pistoia Alliance, ASCP 2024 Vacancy Survey via CriticalValues

The Bottom Line on Laboratory Automation

That wraps up our 40+ lab automation statistics. 

Every firm that tracks the market has it compounding at mid-to-high single digits.

The peer-reviewed evidence shows automation cutting manual steps by 86% and turnaround time by a third. 

And a worsening workforce shortage is making it less a choice than a necessity.

The friction is just as real. Nearly half of labs still can’t get their systems to integrate, the skills gap is widening rather than closing, and most bench staff remain skeptical of the AI layer on top.

So the open question isn’t whether labs will automate. It’s how fast they can absorb it once the market and the staffing math all push the same way.

Thanks for reading. For the wider picture across automation, AI, and the digital lab, see our companion roundup, The Lab of the Future in Numbers: 40+ Statistics on Automation, AI, and the Digital Lab (2026).

And for more independent lab tech articles like this one, subscribe to the BestLabTech newsletter. Every week we send a curated list of the most useful tools, resources, and reads from across the lab tech world.

Lab Automation Statistics FAQ

How big is the laboratory automation market in 2026?

Most research firms value the global lab automation market between USD 6.6 billion and USD 10 billion in 2026, with forecasts reaching USD 8.6 billion to USD 24 billion by the early-to-mid 2030s (Source: MarketsandMarkets, 2026; SNS Insider, 2026). A few firms using a narrower definition estimate closer to USD 2.5 billion, so the figure depends heavily on scope.

What is the ROI of laboratory automation?

In the most detailed published economic evaluation, total laboratory automation paid back its capital cost in about 4.75 years, delivered projected six-year savings of USD 1.88 million, and improved turnaround-time predictability by 70% (Source: Annals of Laboratory Medicine, 2022). A 2026 review reports a comparable four-to-five-year payback from a separate study (Source: Diagnostics, 2026).

How much does lab automation reduce errors and turnaround time?

Total laboratory automation cut discrete manual processing steps by 86% (Source: PMC, 2025), and automating blood-culture diagnostics cut overall turnaround time by 36.7% (Source: Microbiology Spectrum, 2025). It targets the pre-analytical phase, where 50% to 70% of detectable lab errors occur (Source: Diagnostics, 2026).

Why are labs automating?

Mainly staffing. Anatomic pathology labs reported a 28.5% vacancy rate, 10 of 17 departments saw rising retirements, and nearly 40% of labs run more than 100,000 clinical pathology tests a year (Source: ASCP 2024 Vacancy Survey via AABB, 2025; Dark Daily, 2025). Automation covers demand that labs increasingly cannot staff.

Which region leads laboratory automation?

North America leads, contributing about 38% of global revenue in 2025, with the US the largest single market (Source: Mordor Intelligence, 2025; Precedence Research, 2025). Asia Pacific is growing fastest.